Synthesis and characterisation of alginate/chitosan nanoparticles as tamoxifen controlled delivery systems

References

• Ameller T, Legrand P, Marsaud V, Renoir JM. Drug delivery systems for oestrogenic hormones and antagonists: The need for selective targeting in estradiol-dependent cancers. J Steroid Biochem Mol Biol 2004; 92: 1–18
   PubMedGoogle Scholar
• Arias JL, Reddy LH, Couvreur P. Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system. Biomacromolecules 2011; 12: 97–104
   PubMed Web of Science ®Google Scholar
• Azizi E, Namazi A, Haririan I, Fouladdel S, Khoshayand MR, Shotorbani PY, Nomani A, Gazori T. Release profile and stability evaluation of optimized chitosan/alginate nanoparticles as EGFR antisense vector. Int J Nanomed 2010; 5: 455–61
   PubMed Web of Science ®Google Scholar
• Bernardo MV, Blanco MD, Olmo R, Teijón JM. Delivery of bupivacaine included in poly(acrylamide-co-monomethyl itaconate) hydrogels as a function of the pH swelling medium. J Appl Polym Sci 2002; 86: 327–34
   Web of Science ®Google Scholar
• Bernkop-Schnürch A, Kast CE, Richter MF. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release 2001; 71: 277–85
   PubMed Web of Science ®Google Scholar
• Bilensoy E, Sarisozen C, Esendagli G, Dogan AL, Aktas Y, Sen M, Mungan NA. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors. Int J Pharm 2009; 371: 170–6
   PubMed Web of Science ®Google Scholar
• Blanco MD, Guerrero S, Teijón C, Olmo R, Pastrana L, Katime I, Teijón JM. Preparation and characterization of nanoparticulate poly(N-isopropylacrylamide) hidrogel for the controlled release of anti-tumour drugs. Polym Int 2008; 57: 1215–25
   Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002; 249: 127–38
   PubMed Web of Science ®Google Scholar
• Coppi G, Iannuccelli V. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system. Int J Pharm 2009; 367: 127–32
   PubMed Web of Science ®Google Scholar
• Davidenko N, Blanco MD, Peniche C, Becherán L, Guerrero S, Teijón JM. Effects of different parameters on characteristics of chitosan-poly(acrilic acid) nanoparticles obtained by the method of coacervation. J Appl Polym Sci 2009; 111: 2362–71
   Google Scholar
• Efentakis M, Pagoni I, Vlachou M, Avgoustakis K. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility. Int J Pharm 2007; 339: 66–75
   PubMed Web of Science ®Google Scholar
• Egusquiaguirre SP, Igartua M, Hernandez RM, Pedraz JL. Nanoparticle delivery systems for cancer therapy: Advances in clinical and preclinical research. Clin Transl Oncol 2012; 14: 83–93
   PubMed Web of Science ®Google Scholar
• Gurwitz D, Livshits G. Personalized medicine Europe: Health, genes and society: Tel-Aviv University, Tel-Aviv, Israel, June 19–21, 2005. Eur J Hum Genet 2006; 14: 376–80
   PubMedGoogle Scholar
• Hu FX, Neoh KG, Kang ET. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials 2006; 27: 5725–33
   PubMed Web of Science ®Google Scholar
• Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004; 104: 6017–84
   PubMed Web of Science ®Google Scholar
• Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 2003; 257: 169–80
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: The next generation. J Pharm Sci 2000; 89: 850–66
   PubMed Web of Science ®Google Scholar
• Lee KH, Ward BA, Desta Z, Flockhart DA, Jones DR. Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: application to a clinical trial. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 791: 245–53
   PubMed Web of Science ®Google Scholar
• Lee KY, Mooney DJ. Alginate: Properties and biomedical applications. Prog Polym Sci 2012; 37: 106–26
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 2008; 60: 1650–62
   PubMed Web of Science ®Google Scholar
• MacCallum J, Cummings J, Dixon JM, Miller WR. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma. J Chromatogr B Biomed Appl 1996; 678: 317–23
   PubMed Web of Science ®Google Scholar
• Martinez A, Benito-Miguel M, Iglesias I, Teijon JM, Blanco MD. Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems. J Biomed Mater Res A 2012; 100A: 1467–76
   Web of Science ®Google Scholar
• Martínez A, Iglesias I, Lozano R, Teijón JM, Blanco MD. Synthesis and characterization of thiolated alginate-albumin nanoparticles stabilized by disulfide bonds. Evaluation as drug delivery systems. Carbohydrate Polym 2011; 83: 1311–21
   Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Nanomedicine: Current status and future prospects. FASEB J 2005; 19: 311–30
   PubMed Web of Science ®Google Scholar
• Pandey R, Ahmad Z. Nanomedicine and experimental tuberculosis: Facts, flaws, and future. Nanomedicine 2011; 7: 259–72
   PubMed Web of Science ®Google Scholar
• Reis AV, Guilherme MR, Rubira AF, Muniz EC. Mathematical model for the prediction of the overall profile of in vitro solute release from polymer networks. J Colloid Interf Sci 2007; 310: 128–35
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release. I: Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987; 5: 23–36
   Google Scholar
• Romberg B, Hennink WE, Storm G. Sheddable coatings for long-circulating nanoparticles. Pharm Res 2008; 25: 55–71
   PubMed Web of Science ®Google Scholar
• Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release 2003; 90: 261–80
   PubMed Web of Science ®Google Scholar
• Socrates G. Infrared and Raman characteristic group frequencies: Tables and charts3th. John Wiley & Sons, England 2004
   Google Scholar
• Tibbals HF. Medical nanotechnology and nanomedicine. CRC Press, Dallas, TX 2010
   Google Scholar
• Varum FJ, McConnell EL, Sousa JJ, Veiga F, Basit AW. Mucoadhesion and the gastrointestinal tract. Crit Rev Ther Drug Carrier Syst 2008; 25: 207–58
   PubMed Web of Science ®Google Scholar